domingo, 9 de agosto de 2026
Study reveals new role for tau, a top target for Alzheimer’s drug development Stanford scientists pursue mechanism driving protein’s effect on cells in neurodegeneration
https://www.statnews.com/2026/08/06/research-finds-how-tau-targets-cells-structure-alzheimers-drug-development/
By Jonathan WosenAug. 6, 2026
West Coast Biotech & Life Sciences Reporter
FDA approves Replimune melanoma drug previously rejected twice Reversal, capping a tumultuous saga, is a big win for the biotech company, patient advocates
https://www.statnews.com/2026/08/06/replimune-melanoma-drug-rp1-fda-approves-phase-3-confirmatory-trial/
By Elaine ChenAug. 6, 2026
Chen, a national biotech reporter, is the co-author of The Readout, a newsletter about the business, science, and politics of biotech.
Once again, child dies in gene-editing trial in China, rekindling debate on transparency and safety HuidaGene, under loosened oversight, was testing CRISPR therapy in boy with muscular dystrophy
https://www.statnews.com/2026/08/05/china-clinical-trial-fatality-safety-questions-investigator-led-studies/
By Jason Mast and Brian YangAug. 5, 2026
MRI is standard for diagnosing prostate cancer in most western countries. But most U.S. men don’t get them Doctors debate whether biopsies are overused at the expense of scans
https://www.statnews.com/2026/08/05/prostate-cancer-screening-biopsy-vs-mri-debate/?utm_campaign=morning_rounds&utm_medium=email&_hsenc=p2ANqtz-9PMZXKIe3qBx4MUI_gzNSRP7e3B11Yr4QFbMi4fjkFYGC_t_pR00H9HXnmGiZP8WGFMnI7koM6UfM78qlVdfIvT3BGVA&_hsmi=431649944&utm_content=431649944&utm_source=hs_email
By Annalisa MerelliAug. 5, 2026
Contributing Writer
Two-gene interaction reveals metastatic risk in breast cancer
https://www.news-medical.net/news/20260807/Two-gene-interaction-reveals-metastatic-risk-in-breast-cancer.aspx
Why do some breast cancer patients face a much higher risk of distant metastasis, while others with seemingly similar disease experience far better outcomes?
A new study published in Computational Biomedicine suggests that the answer may lie not in the expression of a single gene, but in the interaction between two genes.
Thinning cancer cells' sugar coating could expose tumors to immune attack
https://www.news-medical.net/news/20260807/Thinning-cancer-cells-sugar-coating-could-expose-tumors-to-immune-attack.aspx
Like spies evading detection through being masters of disguise, many cancer cells are adorned with a copious coat of sugar-derived molecules that throws the proverbial hounds of our immune systems off the scent.
Suscribirse a:
Entradas (Atom)

